InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by ARCH Venture Fund XI, L.P.. Director active across 1 company, notably DA32 Life Science Tech Acquisition Corp.. Cumulatively, 3 reports have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €26.9m. Activity tracked since 30 July 2021. The latest transaction was filed on 30 July 2021 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
1,600,000 sharesClass A Common StockSEC:0001062993-23-016233:0
1,600,000 shares@ US$10.0050.0% of flowClass A Common StockSEC:0000899243-21-031417
Ideal exit: 26 Apr 2022 (T+270)
1,600,000 shares@ US$10.0050.0% of flowClass A Common StockSEC:0000899243-21-031417:0
Ideal exit: 26 Apr 2022 (T+270)
3 of 3 declarations
